Survival Outcomes in Stage III to IV Melanoma Before and After the Immunotherapy Era: Persistent Racial and Socioeconomic Disparities. Co-authored by @KalantriShreyas. Read the full article.

Drs. @Charbel_matar1 and @asfeen_ummul share essential tips for confidently navigating the fellowship interview process and securing a successful match. https://t.co/ucF8z45O9T #MedTwitter #OncTwitter

just back from day one of next.js conf. great energy and direction from @rauchg the @vercel team. was great to reconnect with early node folks and the broader @nextjs community…. feels like the ecosystem’s grown up without losing that builder spirit.

Thank you @ASCO for sharing this piece. Appreciated the opportunity to share the insights of @MEmmichDO, @cardismith, @JTrentMDPhD, and Dr. Akeem Lewis. Each offered invaluable advice for early-career oncologists navigating their first contracts. #ASCO25 #ASCOConnection

Stay tuned for our Volunteer Led Webinar, Oct 24, 12:00 CST. @JasmineKambojMD @narvaezdanap @yuan_ruiling @WadeSwenson @ErulEnes @DrYukselUrun @AbiSivaMD @oncodaily @oncologyCOA @HemOncWomenDocs @HemOncFellows @IMG_Oncologists @ASCO #Policy @USOResearch

✅ Moderated a case studies panel ✅ Presented my research 🏆 Honored to be named KYSCO Fellow of the Year All in all, a great KYSCO 2025 fall review meeting! #MedTwitter #OncTwitter

https://t.co/XAnjNPPPvx

‼️🚨 Tonight! Tune in for this great space! ⬇️⬇️⬇️

LIFT Daily Prayer: Mercy, Peace, and Love Multiplied | October 21, 2025 Today’s Verse: Jude 1:2 (NKJV) “Mercy, peace, and love be multiplied to you.” This short verse holds a powerful truth: God doesn’t just give us mercy, peace, and love; He multiplies them. His mercy covers

Thrilled to share our new publication in JCO Oncology Practice! 📄 “Survival Outcomes in Stage III–IV Melanoma Before and After the Immunotherapy Era: Persistent Racial and Socioeconomic Disparities.” Despite major survival gains in the immunotherapy era, inequities persist. 🔗

Thank you @HemOncFellows network for the invitation and looking forward to discussing this important topic

✍️Mark your calendar for our upcoming space❗️ Fellowship Rank Order List: Insights and Practical Tips‼️ 🌟Speaker: @Taha_CancerDoc, Fellowship APD at University of Oklahoma 🌟Host: @DrSAHaddad, Fellow at UT Health San Antonio 🗓️Wednesday, October 15, 2025 📍X space, 6 pm EST

📍SALCS 2025 📌 Poster Presentation of a rare case of liver metastasis from a GI cancer of unknown primary, exploring a potential genetic predisposition with @DrSukeshiArora @LSOM_HemOnc @mayscancer @UTHSAResearch @HemOncFellows @HemOncWomenDocs @hemeoncfellow

It's good to be back! Hi everyone In April this year I found myself confronted with an unexpected health challenge which meant hospital, surgery and a long convalescence. Although I was very ill, I'm on the mend now and back with some simple truths. Going through something

Grateful for the opportunity to present my poster on financial toxicity among Peruvian cancer survivors at #ASCOQLTY25 Stop by Board R5 to learn more! Abstract: https://t.co/ccCrvoevPf #Oncology #GlobOnc #Survivorship #Oncologia #SurvOnc #HOFellows @ASCO #hemonc

Excited to share our work at #ASCOQLTY25! 🩺🎗️ 📍Poster Session B 🗓️ Oct 11, 2025 | ⏰ 7:00–7:55 AM & 12:15–1:30 PM ET 🧾 Abstract: Determinants of Patient-Reported Outcomes Among Hospitalized Cancer Patients Sorry to miss attending in person due to clinical duties, but grateful

Shout out to PGY-5, Dr. Haddad on her poster presentation at #SALCS2025 ! @DrSukeshiArora @JayParekhhh @DanielaUruetamd @mayscancer @UTHSAResearch @HemOncFellows

Half of surveyed pts reported direct involvement in prior authorization ⏱12% spent 41+ hours on 1 authorization 🔢Men, younger pts with employer plans, those with advanced disease commonly face related care delays 🗣️ To be presented at #ASCOQLTY25 https://t.co/2i9RdSjDw0

Because autumn brings less sunlight, cooler & dryer air and more viral exposure, certain nutrients tend to become more important.*

Great start to #ASCOQLTY25 catching up with friends and rockstar health service researchers from UAB! @ASCO

✨ Excited to share that our abstract on conditioning regimens in allogeneic transplant patients has been accepted for poster presentation at #ASH25! Grateful to my incredible mentors for their guidance and support.🙏 Looking forward to connecting and learning from everyone in

Hemonc fellows, check out this episode!! Showing your personality, not only your clinical expertise when you see patients in clinic @HemOncFellows

@healthpolicycop @HemOncFellows @HemOncToday @MayoHemeOnc @MayoMedEd @HemOncWomenDocs Thanks to the amazing work our volunteers are doing. We have a full agenda for upcoming webinar on October 24, 12:00 noon CST. Stay tuned. @yuan_ruiling @WadeSwenson @ErulEnes @DrYukselUrun

An Excerpt from my most recent publication, “Broken Souls” The Destructive Stigma, “Who Is At Fault?” A misunderstanding of the causes of mental illness gives rise to a destructive stigma attaching to the mentally ill. In extreme cases, sufferers may be seen as lazy or weak,

Happy to share our new meta-analysis in JCP (BMJ Group, Q1)! 🔬 We compared 🧊 Frozen Section (FS) vs 🪶 Touch Imprint (TI) for sentinel lymph node biopsy in breast cancer after neoadjuvant therapy. 🎯 We found that FS showed higher sensitivity and specificity than TI 📊